Core Viewpoint - Guoen Technology (02768) experienced a significant stock price increase, reaching a new high of 54.45 HKD, with a current rise of 10.33% to 51.9 HKD and a trading volume of 95.4 million HKD [1] Company Overview - Guoen Technology is a Chinese supplier focused on chemical new materials, gelatin, and collagen upstream and downstream products [1] - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, holding a market share of 2.5% in 2024 [1] - In terms of production capacity, Guoen Technology is projected to be the largest polystyrene company in China by 2024 [1] Market Development - On February 4, the Shenzhen Stock Exchange announced that Guoen Technology's listing on the Hong Kong Stock Exchange does not apply to the price stabilization mechanism, and after 10 trading days of its A-share listing, adjustments to the Hong Kong Stock Connect securities list will take effect from February 4, 2026, including Guoen Technology [1]

Group 1 - The core viewpoint of the article highlights that Guoen Technology (02768) experienced a significant stock price increase, rising over 13% to reach a new high of 54.45 HKD, with a current price of 51.9 HKD and a trading volume of 95.4 million HKD [1][1][1] Group 2 - Guoen Technology is a Chinese supplier focused on chemical new materials, gelatin, and collagen products, and is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, holding a market share of 2.5% as of 2024 [1][1][1] - The company is also the largest polystyrene producer in China by production capacity as of 2024 [1][1][1] Group 3 - On February 4, the Shenzhen Stock Exchange announced that Guoen Technology would be added to the Hong Kong Stock Connect eligible securities list, effective from February 4, 2026, due to its listing on the Hong Kong Stock Exchange not being subject to the price stabilization mechanism [1][1][1]

Core Viewpoint - The collaboration between Kunlun Trust and leading companies in the chemical new materials sector, Zhejiang Satellite Chemical and Jinda Technology, successfully implemented a trial production of green materials, showcasing a new financial solution for industrial chain collaboration [1][15][16]. Group 1: Industry Context - The chemical new materials industry is accelerating towards high-end and green upgrades, necessitating the integration of financial tools into the operational logic of the real economy [1][15]. - Satellite Chemical, a publicly listed company with original technology advantages, utilizes natural gas separation of light hydrocarbons instead of traditional crude oil processes, resulting in products that are low-carbon, low-cost, and high-purity [1][15][16]. Group 2: Financial Innovation - Kunlun Trust has developed an innovative "Trust + SPV" supply chain finance model, enhancing the efficiency of trade execution and resource allocation during the trial phase [1][22]. - The trust structure provides a robust framework for compliance and risk isolation, while the SPV company facilitates efficient capital flow and logistics [22]. Group 3: Collaboration Outcomes - The trial product, polystyrene, benefits from a stable and cost-controlled supply chain, helping Jinda Technology mitigate the pressures of traditional petrochemical raw material price fluctuations [16][22]. - The successful trial has laid a solid foundation for further deepening cooperation between the involved parties [16]. Group 4: Future Directions - Kunlun Trust aims to align with national strategies and key industry needs, expanding its "Trust + Supply Chain" service system to enhance comprehensive financial service capabilities in energy, chemical, advanced manufacturing, and green industries [22].

Group 1 - All newly listed stocks in the Hong Kong market this year have seen an increase on their first trading day, with no stocks experiencing a decline [2] - Guoen Technology (02768.HK) officially listed on the Hong Kong Stock Exchange on February 4, with a significant opening increase of 27%, reaching a price of HKD 45.72 [2] - The public offering of Guoen Technology was oversubscribed by 2,251.85 times, with 3 million shares available for public subscription, accounting for 10% of the total offering [3] Group 2 - The international placement of Guoen Technology was oversubscribed by 10.03 times, with 27 million shares allocated, representing 90% of the total offering [3] - The final offer price for Guoen Technology was set at HKD 36.00 per share, which is in the lower-middle range of the pricing range (HKD 34.00 to HKD 42.00), raising approximately HKD 1 billion in net proceeds [3] - Guoen Technology specializes in chemical new materials and collagen products, serving the chemical and health industries, focusing on R&D, production, and sales [4] Group 3 - Guoen Technology operates within the large chemical industry, covering the entire value chain of chemical new materials, including upstream green petrochemical materials and downstream applications in electronics, automotive, and renewable energy sectors [4] - The company has a complete layout from collagen and derivative raw materials to end products, gradually becoming a comprehensive group in the health sector [4] - For the fiscal years 2022 to 2025, Guoen Technology's revenues are projected to be RMB 13.406 billion, RMB 17.439 billion, RMB 19.188 billion, and RMB 17.444 billion, with corresponding profits of RMB 0.724 billion, RMB 0.540 billion, RMB 0.721 billion, and RMB 0.721 billion [4]

Group 1 - The core viewpoint of the article is that Guoen Technology (02768) has successfully listed on the Hong Kong Stock Exchange, with an initial share price of HKD 36 and a total issuance of 30 million shares, raising approximately HKD 1 billion in net proceeds [1] - As of the report, the stock price has increased by 25%, trading at HKD 45, with a transaction volume of HKD 248 million [1] - Guoen Technology specializes in new chemical materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest company in China for organic polymer modified materials and organic polymer composite materials by sales revenue, holding a market share of 2.5% in 2024 [1] - The company is projected to be the largest producer of polystyrene in China by production capacity in 2024 [1] - On February 4, the Shenzhen Stock Exchange announced that Guoen Technology would be included in the Hong Kong Stock Connect securities list, effective from February 4, 2026, due to its listing on the Hong Kong Stock Exchange not being subject to the price stabilization mechanism [1]

Group 1 - The core viewpoint of the article is that Guoen Technology (02768) has successfully listed on the Hong Kong Stock Exchange, with an initial share price of HKD 36 and a total issuance of 30 million shares, raising approximately HKD 1 billion in net proceeds [1] - As of the report, the stock price has increased by 25%, trading at HKD 45, with a transaction volume of HKD 248 million [1] - Guoen Technology specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries through research, production, and sales of industrial and commercial products [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest company in China in terms of organic polymer modified materials and organic polymer composite materials by sales revenue, holding a market share of 2.5% in 2024 [1] - Additionally, Guoen Technology is projected to be the largest producer of polystyrene in China by production capacity in 2024 [1] - On February 4, the Shenzhen Stock Exchange announced that Guoen Technology would be included in the Hong Kong Stock Connect securities list, effective from February 4, 2026, due to the inapplicability of the price stabilization mechanism for its listing on the Hong Kong Stock Exchange [1]

Group 1 - The core viewpoint of the article is that Guoen Technology (02768) has successfully listed on the Hong Kong Stock Exchange, with an initial share price of HKD 36 and a total issuance of 30 million shares, raising approximately HKD 1 billion in net proceeds [1] - As of the report, the stock price has increased by 25%, trading at HKD 45, with a transaction volume of HKD 248 million [1] - Guoen Technology specializes in new chemical materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries through research, production, and sales of industrial and commercial products [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest company in China in terms of organic polymer modified materials and organic polymer composite materials by sales revenue, holding a market share of 2.5% in 2024 [1] - Additionally, Guoen Technology is projected to be the largest producer of polystyrene in China by production capacity in 2024 [1] - On February 4, the Shenzhen Stock Exchange announced that Guoen Technology would be included in the Hong Kong Stock Connect securities list, effective from February 4, 2026, due to its listing on the Hong Kong Stock Exchange not being subject to the price stabilization mechanism [1]

Core Viewpoint - Guoen Technology is set to launch its global offering on January 27, with a pricing range of HKD 34-42 per share, aiming for a total issuance scale of approximately HKD 10.2 billion to 12.6 billion. The market is discussing the rationality of its pricing, stock price stability post-listing, and long-term valuation logic due to various factors including its business structure and competitive landscape [1][4][11]. Group 1: Financial Performance - Guoen Technology's revenue for 2022-2024 is projected at CNY 134 billion, CNY 174 billion, and CNY 192 billion, with a compound annual growth rate (CAGR) of 19.6%. However, growth is expected to slow to 9.9% in the first ten months of 2025 [2][3]. - The company's net profit has shown significant volatility, with figures of CNY 6.6 billion, CNY 4.7 billion, CNY 6.9 billion, and CNY 7.1 billion for the same periods, reflecting fluctuations of 3.1%, -29.7%, 45.2%, and 40.2% respectively [2][3]. Group 2: Cost Structure and Profitability - Raw material costs account for over 90% of sales costs, leading to limited profitability. The gross margin has declined from 11.8% to 8.3% from 2022 to 2024, with a slight recovery to 10.4% in the first three quarters of 2025 [3][11]. - The health sector shows stronger profitability potential, with a gross margin of 22.5% in the first ten months of 2025, but its revenue contribution is only 3.5%, insufficient to offset the low margins from the chemical sector [3][11]. Group 3: Market Position and Investor Interest - Guoen Technology's market capitalization of CNY 151 billion is the smallest among five concurrent A to H projects, which may reduce its attractiveness to institutional investors [4][5]. - The company has attracted eight cornerstone investors, raising USD 4.1 million, with significant investments from local and health-focused entities, indicating a strategic interest in its health sector [6][8]. Group 4: Market Dynamics and Risks - The absence of a greenshoe option in the offering raises concerns about stock price stability post-listing, as it lacks market support mechanisms [9][10]. - The Hong Kong market's preference for high-growth sectors may limit Guoen Technology's valuation, as its chemical business faces inherent valuation discounts compared to high-margin sectors [11].

Core Insights - The report highlights a mixed performance in the Hong Kong stock market, with the Hang Seng Index rising by 0.51% while the Hang Seng Tech Index fell by 1% [2] - The paper discusses the significant rebound in the real estate sector, with notable increases in stock prices for several property companies, attributed to a more lenient regulatory environment [3] - The consumer sector also showed positive movements, particularly in the sports and beverage segments, indicating a shift in investor sentiment towards traditional sectors amid tech stock volatility [4] Company Overview - The specific company under review, Guo'en Technology (2768.HK), specializes in chemical new materials and gelatin, with a strong focus on organic polymer modified materials and organic polymer composite materials [7] - The company is projected to be the second-largest player in China's organic polymer modified materials market by sales revenue in 2024, holding a market share of 2.5% [7] - Revenue growth is expected to be steady, with total revenues forecasted at approximately RMB 134.1 billion, RMB 174.4 billion, and RMB 191.9 billion for the years 2022, 2023, and 2024 respectively [7] Industry Status and Outlook - The global market for organic polymer modified materials and organic polymer composite materials is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2029, with China's growth rate projected at 14.1% [8] - The largest application for these materials is in the home appliance sector, accounting for 38.2% of usage, followed by the automotive industry at 17.9% [8] Advantages and Opportunities - The company benefits from a vertically integrated model that strengthens its market position in the organic polymer modified materials sector [9] - Strategic expansion into the health sector is part of a dual growth engine strategy, enhancing the company's growth potential [9] - The company has established long-term partnerships with leading enterprises, supported by a strong reputation and innovative capabilities [9] Fundraising Purpose - Approximately 50% of the funds raised (around HKD 528.5 million) will be allocated to establishing a new production base in Thailand to expand capacity [11] - About 35% (around HKD 370.5 million) will be used to enhance the production capacity of the existing facility in Yixing, China [11] - The remaining funds will support operational expenses and general corporate purposes [11] Investment Recommendations - The company ranks second in the organic polymer modified materials sector in China and is the largest producer of polystyrene by capacity [13] - The projected growth in net profit for the first ten months of 2025 is 40% year-on-year, indicating strong financial performance [13] - Despite competitive pressures and potential fluctuations in raw material prices, the company presents a compelling investment opportunity with a significant discount in its valuation compared to its A-share counterpart [13]

Investment Rating - The investment rating for the company is 5.5 out of 10, based on operational performance, industry outlook, valuation, and market sentiment [8]. Core Insights - The company is a leading supplier in China focused on chemical new materials and gelatin, with over 95% of its revenue coming from the large chemical sector. It ranks as the second-largest in organic polymer modified materials and organic polymer composite materials in China, holding a market share of 2.5% [1]. - The company has shown steady revenue growth, with projected revenues of approximately RMB 134.1 billion, 174.4 billion, and 191.9 billion for the years 2022, 2023, and 2024 respectively. In the first ten months of 2025, revenue reached RMB 174.4 billion, reflecting a year-on-year increase of 10% [1]. - The net profit attributable to shareholders for 2022, 2023, and 2024 was RMB 6.63 billion, 4.71 billion, and 6.85 billion respectively, with a significant increase of 40% year-on-year to RMB 7.12 billion in the first ten months of 2025 [1]. Company Overview - The company specializes in green petrochemical materials, including aromatic olefins, styrene, polystyrene, and organic polymer modified materials, which are applied in automotive, new energy, and home appliance sectors. It also operates in the health sector, producing gelatin, collagen, and hollow capsules [1]. - The global market for organic polymer modified materials and organic polymer composite materials is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2029, with China projected to grow at 14.1% [2]. Advantages and Opportunities - The company has established a strong market position in the organic polymer modified materials sector through a vertically integrated model and strategic expansion into the health sector, creating a dual growth engine under its "one body, two wings" strategy [3]. - It has a robust research and development capability, a strong reputation, and long-term partnerships with leading enterprises, supported by a visionary and experienced management team [3].